• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926008300
Medical Device Problem Code Bent (1059)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/20/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event or Problem Description
Same case as mdr id: 2134265-2018-02021.It was reported that stent damage occurred.The 80% stenosed target lesion was located in the calcified right coronary artery (rca).Following pre-dilation with 3.0x20mm and 3.5x15mm nc emerge balloon catheters, a 3.00 x 16mm synergy ii drug-eluting stent was advanced but would not cross the lesion.When the device was removed, it was noted that the stent was not on the balloon.X-ray was performed and it was confirmed that the stent stripped off the balloon in the rca, a guide wire was used to wrap around the stent.The stent, guide catheter and guide wire were removed as one unit.A 3.00 x 8mm synergy ii drug-eluting stent was advanced; however, it was noted that the stent struts got banged up and raised off of the balloon.Multiple additional inflations were then performed using a 3.0x20mm nc emerge balloon catheter and a guide extension catheter.The procedure was completed with another 3.00 x 8mm synergy stent.The patient did not experience any complications.
 
Event or Problem Description
Same case as mdr id: 2134265-2018-02021.It was reported that stent damage occurred.The 80% stenosed target lesion was located in the calcified right coronary artery (rca).Following pre-dilation with 3.0x20mm and 3.5x15mm nc emerge balloon catheters, a 3.00 x 16mm synergy ii drug-eluting stent was advanced but would not cross the lesion.When the device was removed, it was noted that the stent was not on the balloon.X-ray was performed and it was confirmed that the stent stripped off the balloon in the rca, a guide wire was used to wrap around the stent.The stent, guide catheter and guide wire were removed as one unit.A 3.00 x 8mm synergy ii drug-eluting stent was advanced; however, it was noted that the stent struts got banged up and raised off of the balloon.Multiple additional inflations were then performed using a 3.0x20mm nc emerge balloon catheter and a guide extension catheter.The procedure was completed with another 3.00 x 8mm synergy stent.The patient did not experience any complications.
 
Additional Manufacturer Narrative
Device evaluated by mfr., eval summary attached, method codes, result codes, conclusion codes updated.Device evaluated by mfr: the stent delivery system (sds) was returned for analysis.A visual examination of the stent found damage to proximal stent rows 1-2 with stent struts lifted and pulled in a distal direction.The undamaged crimped stent outer diameter (od) was measured and is within maximum crimped stent profile measurement.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple hypotube kinks along the full length of the catheter.This type of damage is consistent with excessive force being applied to the delivery system.A visual and tactile examination of the outer and inner lumen and mid-shaft found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.The investigation conclusion is operational context as the product meets the design and manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7347613
Report Number2134265-2018-02020
Device Sequence Number13649326
Product Code NIQ
UDI-Device Identifier08714729839996
UDI-Public08714729839996
Combination Product (Y/N)N
Initial Reporter StateMT
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/06/2018
Device Model NumberH7493926008300
Device Catalogue Number39260-0830
Device Lot Number0021126352
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/06/2018
Initial Date Received by Manufacturer 02/20/2018
Supplement Date Received by Manufacturer03/22/2018
Initial Report FDA Received Date03/17/2018
Supplement Report FDA Received Date04/12/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age65 YR
-
-